Učitavanje...

Molecular monitoring in chronic myeloid leukemia—how low can you go?

Molecular monitoring of BCR-ABL1 transcripts for patients with chronic myeloid leukemia (CML) is now used to assess response to tyrosine kinase inhibitors (TKIs), including treatment failure that mandates a change of therapy. Therefore, many centers have adopted the molecular technique for measuring...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hematology Am Soc Hematol Educ Program
Glavni autor: Branford, Susan
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142476/
https://ncbi.nlm.nih.gov/pubmed/27913475
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!